Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

2α-Substituted Vitamin D Derivatives Effectively Enhance the Osteoblast Differentiation of Dedifferentiated Fat Cells

Ishizawa M., Takano M., Kittaka A., Matsumoto T., Makishima M.

Animal Study on Systemic / IV, published in Biomolecules (2024) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Biomolecules (2024)
Reported sample size
—
Source database
Europe PMC
PMID
38927109
PMCID
PMC11202298
DOI
10.3390/biom14060706
Citations
1

Abstract (original English)

The active form of vitamin D 3 , 1α,25-dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ], is a principal regulator of calcium homeostasis through activation of the vitamin D receptor (VDR). Previous studies have shown that 2α-(3-hydroxypropyl)-1,25D 3 (O1C3) and 2α-(3-hydroxypropoxy)-1,25D 3 (O2C3), vitamin D derivatives resistant to inactivation enzymes, can activate VDR, induce leukemic cell differentiation, and increase blood calcium levels in rats more effectively than 1,25(OH) 2 D 3 . In this study, to further investigate the usefulness of 2α-substituted vitamin D derivatives, we examined the effects of O2C3, O1C3, and their derivatives on VDR activity in cells and mouse tissues and on osteoblast differentiation of dedifferentiated fat (DFAT) cells, a cell type with potential therapeutic application in regenerative medicine. In cell culture experiments using kidney-derived HEK293 cells, intestinal mucosa-derived CaCO 2 cells, and osteoblast-derived MG63 cells, and in mouse experiments, O2C2, O2C3, O1C3, and O1C4 had a weaker effect than or equivalent effect to 1,25(OH) 2 D 3 in VDR transactivation and induction of the VDR target gene CYP24A1 , but they enhanced osteoblast differentiation in DFAT cells equally to or more effectively than 1,25(OH) 2 D 3 . In long-term treatment with the compound without the medium change (7 days), the derivatives enhanced osteoblast differentiation mor

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Caco-2 CellsAdipocytesOsteoblastsAnimalsHumansMiceCalcitriolVitamin DReceptors, CalcitriolCell Differentiation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research